Prevalence and patterns of the concurrent use of anticholinergics for the motor symptoms of Parkinson’s disease and acetylcholinesterase inhibitors in Parkinson’s disease patients with dementia: a cross-sectional study using Korea National Health Insurance claims data

被引：0
作者：
Deborah Baik
Yun Mi Yu
Sun-Young Jung
Hye-Young Kang
机构：
[1] Yonsei Institute of Pharmaceutical Sciences,College of Pharmacy
[2] Yonsei University,College of Pharmacy
[3] Chung-Ang University,undefined
来源：
BMC Geriatrics | / 22卷
关键词：
Acetylcholinesterase inhibitor; Cholinergic antagonist; Drug utilization; Insurance claims data; Parkinson’s disease; Dementia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
  • [1] Kehagia AA(2010)Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease Lancet Neurol 9 1200-1213
  • [2] Barker RA(2016)Epidemiology of Parkinson Disease Neurol Clin 34 955-965
  • [3] Robbins TW(2019)Patterns of dementia treatment and frank prescribing errors in older adults with Parkinson Disease JAMA Neurol 76 41-49
  • [4] Lee A(2016)Prevalence and treatment pattern of Parkinson’s disease dementia in Korea Geriatr Gerontol Int 16 230-236
  • [5] Gilbert RM(2014)Pharmacological treatment of Parkinson disease: a review JAMA 311 1670-1683
  • [6] Mantri S(2017)Parkinson’s disease: summary of updated NICE guidance BMJ 358 j1951-532
  • [7] Fullard M(2014)Inappropriate treatments for patients with cognitive decline Neurologia 29 523-94
  • [8] Gray SL(2014)A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples Epidemiol Health 36 e2014008-S112
  • [9] Weintraub D(2019)American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults J Am Geriatr Soc 67 674-650
  • [10] Hubbard RA(2014)Second-generation antipsychotics and extrapyramidal adverse effects Biomed Res Int 2014 656370-925
1234